KRYS· Krystal Biotech Inc.
Insider buys/sells · last 6 mo · open market only
| Transactions | Total $ | |
|---|---|---|
| Buys | 0 | $0 |
| Sells | 52 | $41M |
Quarterly ownership history
Last 6 quarters
KRYS Financials
Live via yfinance — refreshed daily.
Valuation
Market capitalization$9.0B
Enterprise value$8.2B
EV / EBITDA (TTM)45.43
P/E ratio (TTM)40.98
Forward P/E29.94
P/S ratio21.60
P/B ratio7.32
PEG ratio—
Cash Flow
Operating cash flow (TTM)$250M
Free cash flow (TTM)$137M
Total cash$823M
Total debt$9M
Debt / equity0.71
Current ratio9.46
Income Statement
Total revenue (TTM)$417M
Revenue per share (TTM)14.36
Gross profit (TTM)$393M
EBITDA (TTM)$180M
Net income (TTM)$225M
EPS diluted (TTM)7.46
Shares outstanding29,479,756
Float shares23,369,782
Profitability
Gross margin94.17%
Operating margin46.14%
EBITDA margin43.25%
Net margin53.92%
Efficiency
Return on assets (TTM)9.04%
Return on equity (TTM)19.90%
Price History
Current price$305.71
52 Week high$306.10
52 Week low$122.80
50 day average$264.04
200 day average$221.29
Average volume (10 day)346,990
1-year beta0.49
1-year price target$318.22
Dividends
Dividend yield—
Dividend rate (annual)—
Payout ratio0.00%
Fundamentals are sourced from yfinance and refreshed daily. Last updated May 10, 2026, 5:39 PM. Empty cells (—) mean yfinance doesn't have that field for this ticker (common for ADRs, recent IPOs, or non-applicable ratios).
Real-time alerts. We'll let you know when a whale you follow files a new 13F, or a stock you follow has insider activity. No weekly digest.
whalstreet
★ WatchlistData from SEC EDGAR · whalstreet.com